Kuros Biosciences Ltd.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Kuros Biosciences is a medical technology company that discovers, develops, and delivers innovative biologic technologies for tissue repair and bone regeneration. The company's primary focus is on improving outcomes in spinal fusion surgery to address high rates of failed fusions. Its main product is MagnetOs, a bone graft featuring proprietary NeedleGrip™ surface technology, which is designed to grow bone even in soft tissues for more predictable fusions. Kuros Biosciences supports its products through 'Project Fusion,' a global research program that combines scientific, pre-clinical, and clinical studies. The company operates globally with a commercial and research footprint across three continents and more than 20 markets.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Kuros Biosciences Ltd..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-14 02:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2025 Results
|
English | 22.7 KB | |
| 2025-03-11 01:00 |
Earnings Release
Kuros Biosciences grows sales to CHF 75.6 million for 2024
|
English | 19.2 KB | |
| 2025-01-08 07:00 |
Legal Proceedings Report
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | |
| 2025-01-07 07:00 |
Regulatory News Service
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | |
| 2025-01-07 01:00 |
M&A Activity
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 11.8 KB | |
| 2024-11-19 07:00 |
Board/Management Information
Kuros Biosciences Expands into Extremities Markets
|
English | 18.5 KB | |
| 2024-11-19 01:00 |
Board/Management Information
Kuros Biosciences Expands into Extremities Markets
|
English | 16.1 KB | |
| 2024-10-10 02:00 |
Earnings Release
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow brea…
|
English | 16.3 KB | |
| 2024-08-08 07:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
|
English | 37.6 KB | |
| 2024-08-08 02:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
|
English | 33.0 KB | |
| 2024-06-25 07:00 |
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 17.2 KB | |
| 2024-06-25 02:00 |
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 14.9 KB | |
| 2024-04-24 07:00 |
Earnings Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct M…
|
English | 17.0 KB | |
| 2024-04-24 02:00 |
Earnings Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct M…
|
English | 14.9 KB | |
| 2024-04-17 14:05 |
Post-Annual General Meeting Information
Annual General Meeting of Kuros Biosciences approves all resolutions
|
English | 10.3 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
